Search

Timothy H Weng

from Cooper City, FL
Age ~71
Get Report
Also known as:
Ho Lun Weng, Timothy H Wang, Ho L Weng, Lun Weng Ho, Lun Weng Holun, Tim Wang, Wen Ho
Related to:
Ming Wang LeemingLun Weng HolunCarol Sleek, 43Alice C Wong, 56Ching Y Ly, 62Ho L Weng, 71Benjamin O Sleek, 45Jeanie Weng, 70Chingying JlySuchuan Ly
Connected to:
Anna Y Weng, 72Chenjiou Weng, 52Danny Y Weng, 35Deborah J Weng, 43Edward E Weng, 36Gina Weng, 55Haiming M Weng, 54Hsiao C Weng, 42Irene M Weng, 82Joy L Weng, 59

Timothy Weng Phones & Addresses

  • Cooper City, FL
  • 3717 Lear Ct, Wilson, NC 27896
  • 3717B Lear Ct NW, Wilson, NC 27896
  • 4204 88Th Ave, Sunrise, FL 33351
  • Plantation, FL
  • 31 Bedminster Rd, Randolph, NJ 07869
  • Piscataway, NJ
  • Flushing, NY
  • Ledgewood, NJ

Resumes

Resumes

Timothy Weng Photo 1

Sr Vp, R&D At Actavis Southatlantic

View page
Location:
Miami/Fort Lauderdale Area
Industry:
Pharmaceuticals
Timothy Weng Photo 2

Timothy Weng

View page
Location:
Miami/Fort Lauderdale Area
Industry:
Pharmaceuticals

Publications

Us Patents

Omeprazole Formulation

View page
US Patent:
6780435, Aug 24, 2004
Filed:
Oct 23, 2002
Appl. No.:
10/279622
Inventors:
Chih-Ming Chen - Davie FL
Joseph C. H. Chou - Coral Springs FL
Timothy Weng - Plantation FL
Assignee:
Andrx Pharmaceuticals, Inc. - Davie FL
International Classification:
A61K 914
US Classification:
424489, 424400, 424490, 424493, 424494, 424497
Abstract:
A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of: (a) a pellet comprising an inert core component, a therapeutically effective amount of omeprazole, a surface active agent, a filler, a pharmaceutically acceptable alkaline agent and a binder; and (b) a single layer of coating on said pellet which comprises a layer of an enteric coating agent.

Once A Day Antihistamine And Decongestant Formulation

View page
US Patent:
6994871, Feb 7, 2006
Filed:
Sep 16, 2002
Appl. No.:
10/244452
Inventors:
Mongkol Sriwongjanya - Davie FL, US
Timothy Weng - Bayside NY, US
David Barman - North Miami Beach FL, US
Unchalee Kositprapa - Davie FL, US
Assignee:
Andrx Pharmaceuticals, Inc. - Davie FL
International Classification:
A61K 9/20
A61K 9/22
A61K 9/24
A61K 9/26
US Classification:
424464, 424468, 424469, 424470, 424471, 424472, 424473
Abstract:
A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the immediate release of the antihistamine.

Controlled Release Bupropion Dosage Forms

View page
US Patent:
20060257483, Nov 16, 2006
Filed:
May 10, 2005
Appl. No.:
11/125857
Inventors:
Tianrun Yang - Coral Springs FL, US
Timothy Weng - Cooper City FL, US
Assignee:
ABRIKA Pharmaceuticals - Sunrise FL
International Classification:
A61K 9/24
A61K 31/195
US Classification:
424471000, 514563000
Abstract:
A controlled release pharmaceutical dosage form comprising bupropion or pharmaceutically acceptable salt thereof.

Dosage Forms Comprising A Short Acting Sedative-Hypnotic Or Salt Thereof

View page
US Patent:
20070286902, Dec 13, 2007
Filed:
Jun 7, 2006
Appl. No.:
11/448199
Inventors:
Jianbo Xie - Davie FL, US
Timothy Weng - Cooper City FL, US
Mongkol Sriwongjanya - Pembroke Pines FL, US
Assignee:
ABRIKA Pharmaceuticals - Sunrise FL
International Classification:
A61K 31/4745
A61K 9/22
US Classification:
424468, 514303
Abstract:
In certain embodiments the invention is directed to an oral solid pharmaceutical dosage form comprising: a first portion of a short acting sedative-hypnotic in an release immediate release component; and a second portion of the sedative-hypnotic in a delayed component, the delayed release component comprising (i) a unitary core comprising the second portion of sedative-hypnotic dispersed in a controlled release matrix and (ii) a delayed release coating surrounding the core.

Controlled Release Alfuzosin Hydrochloride Formulation

View page
US Patent:
20070292505, Dec 20, 2007
Filed:
Jun 15, 2006
Appl. No.:
11/453651
Inventors:
Tianrun Yang - Coral Springs FL, US
Timothy Weng - Cooper City FL, US
Assignee:
Abrika Pharmaceuticals, Inc. - Sunrise FL
International Classification:
A61K 9/22
A61K 31/496
US Classification:
424468, 51425217
Abstract:
In certain embodiments the invention is directed to a single layer controlled release pharmaceutical formulation comprising a tablet consisting of a single layer matrix comprising a therapeutically effective amount of alfuzosin or a pharmaceutically acceptable salt thereof dispersed in a controlled release material, wherein the formulation following single dose administration under fed conditions exhibits a mean time to maximum plasma concentration of about 3 hours to about 14 hours.

Controlled Release Oral Dosage Form

View page
US Patent:
61563420, Dec 5, 2000
Filed:
May 26, 1998
Appl. No.:
9/084622
Inventors:
Mongkol Sriwongjanya - Davie FL
Timothy Weng - Plantation FL
Joseph Chou - Coral Springs FL
Chih-Ming Chen - Davie FL
Assignee:
Andex Pharmaceuticals, Inc. - Fort Lauderdale FL
International Classification:
A61K 924
A61K 928
US Classification:
424473
Abstract:
A controlled release dosage form for an analgesic that does not contain an expanding polymer and comprising a core containing the analgesic, preferably tramadol or it pharmaceutically acceptable deviates and a semipermeable membrane coating the core.

Omeprazole Formulation

View page
US Patent:
60963409, Aug 1, 2000
Filed:
Nov 14, 1997
Appl. No.:
8/970489
Inventors:
Chih-Ming Chen - Davie FL
Joseph C. H. Chou - Coral Springs FL
Timothy Weng - Plantation FL
Assignee:
Andrx Pharmaceuticals, Inc. - Fort Lauderdale FL
International Classification:
A61K 934
US Classification:
424480
Abstract:
A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of: (a) a pellet comprising an inert core component, a therapeutically effective amount of omeprazole, a surface active agent, a filler, a pharmaceutically acceptable alkaline agent and a binder; and (b) a single layer of coating on said pellet which comprises a layer of an enteric coating agent.

Prevention Of Ibuprofen From Forming Low Melting Eutectics With Other Therapeutic Agents In Solid Dosage Forms

View page
US Patent:
55123007, Apr 30, 1996
Filed:
Sep 15, 1992
Appl. No.:
7/945203
Inventors:
Timothy H. Weng - Randolph NJ
Michael G. Williams - Flanders NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 910
A61K 914
A61K 916
A61K 920
US Classification:
424465
Abstract:
A method for preparing ibuprofen granulations which exhibit improved stability and resistance to the formation of low melting point eutectics is disclosed. The method includes forging an amalgamation of ibuprofen and an alkali metal in a physical matrix which is suitable for inclusion in a composition without destroying the amalgamation. The stabilized ibuprofen granulation can be combined with other active ingredients and/or excipients to form compositions which have extended shelf life and are resistant to the formation of low melting point eutectics.
Control profile
Timothy H Weng from Cooper City, FL, age ~71 Get Report